Recombinant Human Epidermal Growth Factor Specifications
Product Name
| Recombinant Human Epidermal Growth Factor
|
Species
| Human
|
Source
| Pichia pastoris
|
Appearances
| White or off-white lyophilized powder
|
Molecular weight
| 6.0kD±0.6 kD
|
Purity
| ≥95%(SDS-PAGE) ≥95%(RP-HPLC)
|
Endotoxin
| < 0.2 EU/µg
|
Active
| ≥1.2×106U/mg pro |
Solubility
| Good solubility in water, buffer, and medium
|
Storage Conditions
| -15℃ below, protected from light, sealed
|
The data should be subject to test report of products.
Recombinant EGF Application
Recombinant human EGF is widely used in cell culture of fibroblasts, keratinocytes, epithelial cells and endothelial
cells.
Recombinant Human EGF Recommended Method
It is recommended to centrifuge the powder to the bottom of the tube before opening the lid, then dissolve it in sterilized deionized water to prepare a storage solution of 100 μg/ml. The recombinant human EGF can be stored stably for 1 week at 2~ 8 ℃ . When diluted to a lower concentration (not less than 10μg/ml), 0.1% tissue culture grade BSA or HSA is required. If it is necessary to extend the storage time, it is recommended to freeze at -70 ℃ or -20 ℃ rather than multigelation. The EGF epidermal growth factor should be determined by experiment to determine the optimum concentration according to each specific application.

EGF Epidermal Growth Factor Transport and Storage Stability
Notice and Disclaimer for EGF Human Recombinant